RVP Retractable Technologies Inc.

Retractable Technologies, Inc. Reports Results as of June 30, 2017

Retractable Technologies, Inc. (NYSE American: RVP) reports the following results of operations for the three and six months ended June 30, 2017 and 2016, respectively.

Comparison of Three Months Ended June 30, 2017 and June 30, 2016

Domestic sales accounted for 79.2% and 91.7% of the revenues for the three months ended June 30, 2017 and 2016, respectively. Domestic revenues decreased 12.8% principally due to decreases in sales of 1mL and 3mL syringes and the EasyPoint® needle. Domestic unit sales decreased 14.1%. Domestic unit sales were 69.8% of total unit sales for the three months ended June 30, 2017. International revenue and unit sales increased 152.3% and 225.5%, respectively, due to the timing of several large orders. Our international orders may be subject to significant fluctuation over time. Overall unit sales increased 10.5%.

Gross profit decreased 15.6% primarily due to lower domestic sales volumes.

The Cost of manufactured product increased by 12.5% principally due to larger volumes sold. Profit margins can fluctuate depending upon, among other things, the cost of manufactured product and the capitalized cost of product recorded in inventory, as well as product sales mix. Royalty expense decreased 6.9% due to lower gross sales.

Operating expenses increased 9.0% or $290 thousand. The increase was due to stock option expense and increased staffing in sales and marketing. Our legal expenses declined.

Our operating loss was $1.3 million compared to an operating loss for the same period last year of $605 thousand due primarily to lower gross profit and higher operating expenses.

Our effective tax rate on the net loss before income taxes was 0.0% and (0.1)% for the three months ended June 30, 2017 and June 30, 2016, respectively.

Comparison of Six Months Ended June 30, 2017 and June 30, 2016

Domestic sales accounted for 82.4% and 92.2% of the revenues for the six months ended June 30, 2017 and 2016, respectively. Domestic revenues decreased 3.6% principally due to lower volume. Domestic unit sales decreased 5.4%. Domestic unit sales were 75.2% of total unit sales for the six months ended June 30, 2017. International revenue and unit sales increased 144.6% and 183.4%, respectively, due to the timing of several large orders. Our international orders may be subject to significant fluctuation over time. Overall unit sales increased 13.3%.

Gross profit decreased 5.7% primarily due to higher per unit cost of manufacture.

The Cost of manufactured product increased 17.5% due to larger volumes and higher manufacturing cost per unit. Profit margins can fluctuate depending upon, among other things, the cost of manufactured product and the capitalized cost of product recorded in inventory, as well as product sales mix. Royalty expense increased 3.0% due to higher gross sales.

Operating expenses increased 10.8% or $683 thousand. The increase was due to stock option expense and increased staffing in sales and marketing. We also awarded bonuses to two officers in the first quarter. Our legal expenses declined.

Our operating loss was $2.5 million compared to an operating loss for the same period last year of $1.5 million due primarily to higher operating expenses and lower gross profit.

Our effective tax rate on the net loss before income taxes was 0.0% and (0.1)% for the six months ended June 30, 2017 and June 30, 2016, respectively.

Further details concerning the results of operations as well as other matters are available in Retractable’s 10-Q filed on August 14, 2017 with the U.S. Securities and Exchange Commission.

Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe® syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint® is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint® needle also can be used to aspirate fluids and for blood collection. Retractable's products are distributed by various specialty and general line distributors.

For more information on Retractable, visit its website at www.retractable.com.

Forward-looking statements in this press release are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 and reflect Retractable's current views with respect to future events. Retractable believes that the expectations reflected in such forward-looking statements are accurate. However, Retractable cannot assure you that such expectations will materialize. Actual future performance could differ materially from such statements.

Factors that could cause or contribute to such differences include, but are not limited to: Retractable's ability to maintain liquidity; Retractable's maintenance of patent protection; the impact of current and future Court decisions regarding current litigation; Retractable's ability to maintain favorable third party manufacturing and supplier arrangements and relationships; foreign trade risk; Retractable's ability to quickly increase capacity in response to an increase in demand; Retractable's ability to access the market; Retractable's ability to maintain or lower production costs; Retractable's ability to continue to finance research and development as well as operations and expansion of production; the impact of larger market players, specifically Becton, Dickinson and Company, in providing devices to the safety market; and other risks and uncertainties that are detailed from time to time in Retractable's periodic reports filed with the U.S. Securities and Exchange Commission.

EN
14/08/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Retractable Technologies Inc.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

TRGP TARGA RESOURCES CORP.
XHR XENIA HOTELS & RESORTS INC.
TGI TRIUMPH GROUP INC.
SRT STARTEK INC.
SIG SIGNET JEWELERS LIMITED
RYAM RAYONIER ADVANCED MATERIALS INC
PLCE CHILDREN'S PLACE INC.
PEB PEBBLEBROOK HOTEL TRUST
PANW PALO ALTO NETWORKS INC.
OLLI OLLIE'S BARGAIN OUTLET HOLDINGS INC
NSTG NANOSTRING TECHNOLOGIES
MSGN MSG NETWORKS INC. CLASS A
M MACY'S INC
KSS KOHL'S CORPORATION
JWN NORDSTROM INC.
INSM INSMED INCORPORATED
FOSL FOSSIL GROUP INC.
DMRC DIGIMARC CORPORATION
CLDT CHATHAM LODGING TRUST
CDNA CAREDX INC
BCO BRINK'S COMPANY
AXTI AXT INC.
AVID AVID TECHNOLOGY INC.
ATRA ATARA BIOTHERAPEUTICS INC
SKY SKYLINE CHAMPION CORPORATION
PZN PZENA INVESTMENT MANAGEMENT
MEG. MEG ENERGY CORP.
MDP MED PAPER S.A.
DVN DEVINE
DRH DIAMONDROCK HOSPITALITY COMPANY
NRP NATURAL RESOURCE PARTNERS L.P.
OXM OXFORD INDUSTRIES INC.
PVH PVH CORP.
RL RALPH LAUREN CORPORATION CLASS A
SHSP SHARPSPRING
VRA VERA BRADLEY INC.
RVP RETRACTABLE TECHNOLOGIES INC.
LCUT LIFETIME BRANDS
TTD TRADE DESK INC. CLASS A
FNKO FUNKO CLASS A
RBBN RIBBON COMMUNICATIONS
RIOT RIOT BLOCKCHAIN
EHC ENCOMPASS HEALTH CORPORATION
RCKT ROCKET PHARMACEUTICALS
APLS APELLIS PHARMACEUTICALS
BLNK BLINK CHARGING
UPWK UPWORK
FKWL FRANKLIN WIRELESS CORP.
HYRE HYRECAR
CPRI CAPRI HOLDINGS LIMITED
GSL GLOBAL SHIP LEASE INC. CLASS A
VEL VELOCITY FINANCIAL INC
DAC DANAOS
VLDR VELODYNE LIDAR INC
GBTC GRAYSCALE BITCOIN TRUST (BTC)
CHX CHAMPIONX CORPORATION
FUBO FUBOTV
GII SPDR S&P GLOBAL INFRASTRUCTURE
SLQT SELECTQUOTE
TCRR INC.
GMDA TCR2 THERAPEUTICS
INC.
GAMIDA CELL LTD

Retractable Technologies Inc: 1 director bought

A director at Retractable Technologies Inc bought 4,200 shares at 5.920USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

W WAYFAIR INC.
DXCM DEXCOM INC.
SHOP SHOPIFY INC.
INCY INCYTE CORP
RGLD ROYAL GOLD INC
NEM NEWMONT CORPORATION
VEEV VEEVA SYSTEMS INC CLASS A
QRVO QORVO INC.
NUE NUCOR CORPORATION
NOW SERVICENOW INC.
MASI MASIMO CORPORATION
ZBRA ZEBRA TECHNOLOGIES CORPORATION CLASS A
TSCO TRACTOR SUPPLY COMPANY
TECH BIO-TECHNE CORPORATION
TEAM ATLASSIAN CORP. PLC CLASS A
SMG SCOTTS MIRACLE-GRO COMPANY CLASS A
SFM SPROUTS FARMERS MARKETS INC.
RP REALPAGE INC.
ROK ROCKWELL AUTOMATION INC.
PZZA PAPA JOHN'S INTERNATIONAL INC.
PYPL PAYPAL HOLDINGS INC
PRLB PROTO LABS INC.
NERV MINERVA NEUROSCIENCES
MSCI MSCI INC. CLASS A
MPWR MONOLITHIC POWER SYSTEMS INC.
MOH MOLINA HEALTHCARE INC.
MNTA MOMENTA PHARMACEUTICALS INC.
MKTX MARKETAXESS HOLDINGS INC.
LMNX LUMINEX CORP
HZNP HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
HALO HALOZYME THERAPEUTICS INC.
GFI GOLD FIELDS LTD. ADS
FFIV F5 NETWORKS INC.
ETSY ETSY INC.
ELMD ELECTROMED
EBS EMERGENT BIOSOLUTIONS INC.
EBAY EBAY INC.
CYTK CYTOKINETICS INCORPORATED
CTMX CYTOMX THERAPEUTICS INC.
CTLT CATALENT INC
CIEN CIENA CORPORATION
CHMA CHIASMA
CHGG CHEGG INC.
CDNA CAREDX INC
VPA1 AVEO PHARMACEUTICALS INC.
AUDC AUDIOCODES LTD.
AU ANGLOGOLD ASHANTI LTD. ADS
AKBA AKEBIA THERAPEUTICS INC.
AGI. ALAMOS GOLD INC.
ADVM ADVERUM BIOTECHNOLOGIES
AAWW ATLAS AIR WORLDWIDE HOLDINGS INC.
K. KINROSS GOLD CORPORATION
CCO. CAMECO CORPORATION
SWKS SKYWORKS SOLUTIONS INC.
MAG. MAG SILVER CORP.
AEM. AGNICO EAGLE MINES LIMITED
ELA ELAND OIL & GAS
FREJA VERISEC AB
BIO BIO-RAD LABORATORIES INC. CLASS A
EA ELECTRONIC ARTS INC.
LSCC LATTICE SEMICONDUCTOR CORPORATION
MRTN MARTEN TRANSPORT LTD.
ODFL OLD DOMINION FREIGHT LINE INC.
SAM BOSTON BEER COMPANY INC. CLASS A
TREX TREX COMPANY INC.
WERN WERNER ENTERPRISES INC.
MTSI MACOM TECHNOLOGY SOLUTIONS HOLDINGS INC.
WMK WEIS MARKETS INC.
RVP RETRACTABLE TECHNOLOGIES INC.
CC CHEMOURS CO.
FLWS 1-800-FLOWERS.COM CL A
X UNITED STATES STEEL CORPORATION
COUP COUPA SOFTWARE INC.
SNDX SYNDAX PHARMACEUTICALS
KNSL KINSALE CAPITAL GROUP INC.
CDXC CHROMADEX CORP
IRTC IRHYTHM TECHNOLOGIES INC.
SPGI S&P GLOBAL INC.
SSRM SSR MINING INC
SPRO SPERO THERAPEUTICS
SE SEA ADS
BAND BANDWIDTH CLASS A
SIGA SIGA TECHNOLOGIES INC.
SMAR SMARTSHEET
AZN ASTRAZENECA PLC ADS
DOCU DOCUSIGN INC.
DUBA DRDGOLD LTD. ADS
SCPL SCIPLAY
AVTR AVANTOR INC.
VAPO VAPOTHERM
GNMSY GENMAB A/S
ADPT ADAPTIVE BIOTECHNOLOGIES CORP.
ZYXI ZYNEX
CGEN COMPUGEN LTD.
 PRESS RELEASE

Retractable Technologies, Inc. Files Motions in Connection with Becton...

LITTLE ELM, Texas--(BUSINESS WIRE)-- Retractable Technologies, Inc. (NYSE American: RVP), (“RTI”) reports that on September 13, 2017, it filed a Motion to Alter or Amend the Judgment issued by the United States District Court for the Eastern District of Texas on August 17, 2017 which had ordered that RTI take nothing in its suit against Becton, Dickinson and Co. (“BD”). Such Motion asked the Court to require BD to notify end users of the facts relating to syringes, as required by the original injunction in this case. R...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch